Standard
License to kill : formulation requirements for optimal priming of CD8+ CTL responses with particulate vaccine delivery systems. / Foged, Camilla; Hansen, Jon; Agger, Else Marie.
I:
European Journal of Pharmaceutical Sciences, Bind 45, Nr. 4, 2012, s. 482-491.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Foged, C, Hansen, J & Agger, EM 2012, '
License to kill: formulation requirements for optimal priming of CD8+ CTL responses with particulate vaccine delivery systems',
European Journal of Pharmaceutical Sciences, bind 45, nr. 4, s. 482-491.
https://doi.org/10.1016/j.ejps.2011.08.016
APA
Foged, C., Hansen, J., & Agger, E. M. (2012).
License to kill: formulation requirements for optimal priming of CD8+ CTL responses with particulate vaccine delivery systems.
European Journal of Pharmaceutical Sciences,
45(4), 482-491.
https://doi.org/10.1016/j.ejps.2011.08.016
Vancouver
Foged C, Hansen J, Agger EM.
License to kill: formulation requirements for optimal priming of CD8+ CTL responses with particulate vaccine delivery systems.
European Journal of Pharmaceutical Sciences. 2012;45(4):482-491.
https://doi.org/10.1016/j.ejps.2011.08.016
Author
Foged, Camilla ; Hansen, Jon ; Agger, Else Marie. / License to kill : formulation requirements for optimal priming of CD8+ CTL responses with particulate vaccine delivery systems. I: European Journal of Pharmaceutical Sciences. 2012 ; Bind 45, Nr. 4. s. 482-491.
Bibtex
@article{056def89d78e4eb0aacbecdbd6585820,
title = "License to kill: formulation requirements for optimal priming of CD8+ CTL responses with particulate vaccine delivery systems",
keywords = "Former Faculty of Pharmaceutical Sciences",
author = "Camilla Foged and Jon Hansen and Agger, {Else Marie}",
year = "2012",
doi = "10.1016/j.ejps.2011.08.016",
language = "English",
volume = "45",
pages = "482--491",
journal = "Norvegica Pharmaceutica Acta",
issn = "0928-0987",
publisher = "Elsevier",
number = "4",
}
RIS
TY - JOUR
T1 - License to kill
T2 - formulation requirements for optimal priming of CD8+ CTL responses with particulate vaccine delivery systems
AU - Foged, Camilla
AU - Hansen, Jon
AU - Agger, Else Marie
PY - 2012
Y1 - 2012
KW - Former Faculty of Pharmaceutical Sciences
U2 - 10.1016/j.ejps.2011.08.016
DO - 10.1016/j.ejps.2011.08.016
M3 - Journal article
C2 - 21888971
VL - 45
SP - 482
EP - 491
JO - Norvegica Pharmaceutica Acta
JF - Norvegica Pharmaceutica Acta
SN - 0928-0987
IS - 4
ER -
